Clinical Evaluation of 177Lu-PSMA-VG01 Injection in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer （mCRPC）

NCT07660211 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
10
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

VitsGen Therapeutics Inc.